Skip to main content
SPNT
NYSE Finance

SiriusPoint Q3 EPS $0.74, Operating EPS $0.88; RiverStone LPT to Unlock $200M+

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Positive
Importance info
8
Price
$26.27
Mkt Cap
$3.052B
52W Low
$19.045
52W High
$26.905
52W Position info
38% above low
Off High info
2.4% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

SPNT sits 38% above its 52-week low of $19.045.

Summary

SiriusPoint posted Q3 operating EPS of $0.88, up 19%, and agreed a loss portfolio transfer with RiverStone covering its remaining run-off reserves — expected to unlock over $200 million of capital pending regulatory approval.


Key Events · Earnings and Guidance · SPNT

  • Q3 Operating EPS Up 19%

    Net income available to common shareholders was $87 million, or $0.74 per diluted share. Operating EPS rose 19% to $0.88, on a 90.1% core combined ratio and 17.6% operating ROE.

  • RiverStone LPT on Run-Off Reserves

    The loss portfolio transfer covers substantially all remaining run-off reserves with a $700 million aggregate limit. It is expected to unlock over $200 million of capital, subject to regulatory approval.

  • ~$60M Day-One Charge, BSCR +20pts

    Closing the LPT carries an estimated ~$60 million day-one pre-tax charge, versus an average $12 million quarterly run-off loss since Q4'23. The deal is expected to lift the BSCR ratio by roughly 20 points.

  • Segment Realignment From Q4 2026

    SiriusPoint plans to report Accident & Health (over $1 billion of premiums) as a standalone segment alongside a new Specialty P&C segment, replacing Insurance & Services and Reinsurance.


Analysis · SPNT · Finance

The headline numbers were solid: operating EPS rose 19% to $0.88 on a 90.1% core combined ratio and 17.6% operating ROE. But the more consequential development is the loss portfolio transfer with RiverStone covering substantially all remaining run-off reserves. That deal is expected to unlock over $200 million of capital and lift the BSCR ratio by roughly 20 points, at the cost of an estimated ~$60 million day-one pre-tax charge. In effect, it closes out the legacy book that has weighed on results. Separately, the company is realigning into Accident & Health and Specialty P&C segments from Q4 2026. The LPT still requires regulatory approval, so the capital release is not yet in hand.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SPNT was trading at $26.27 on NYSE in the Finance sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $19.05 to $26.91. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SPNT - Latest Insights

SPNT
Nov 05, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $26.27
Real-time Price: $26.55 info
Change: +$0.275 (+1%) info
Market Cap: $3.036B info
SPNT
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $26.27
Real-time Price: $26.55 info
Change: +$0.275 (+1%) info
Market Cap: $3.036B info
SPNT
Jul 29, 2026, 4:28 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $25.81
Real-time Price: $26.55 info
Change: +$0.735 (+3%) info
Market Cap: $3.036B info
SPNT
Jul 29, 2026, 4:15 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $25.81
Real-time Price: $26.55 info
Change: +$0.735 (+3%) info
Market Cap: $3.036B info
SPNT
Jul 29, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $25.81
Real-time Price: $26.55 info
Change: +$0.735 (+3%) info
Market Cap: $3.036B info